Literature DB >> 17177110

LXR alpha transactivates mouse organic solute transporter alpha and beta via IR-1 elements shared with FXR.

Masae Okuwaki1, Tappei Takada, Yuki Iwayanagi, Saori Koh, Yoshiaki Kariya, Hiroshi Fujii, Hiroshi Suzuki.   

Abstract

PURPOSE: Recently identified organic solute transporter (Ost) alpha and beta are located on the basolateral membrane of enterocytes and may be responsible for the intestinal absorption of many substrates including bile acids. In the present study, the mechanism governing the transcriptional regulation of their expression was investigated. METHODS AND
RESULTS: To clarify the transcriptional regulation of Osts, reporter gene assays were performed using mouse Ostalpha/beta promoter-luciferase reporter constructs. Co-transfection of the constructs with farnesoid X receptor (FXR) and retinoid X receptor alpha (RXRalpha) or liver X receptor alpha (LXRalpha) and RXRalpha into Caco-2 cells induced the transcriptional activities of both Ost alpha and beta and further increases were observed following treatment with each agonist. Sequence analyses indicated the presence of IR-1 regions in Ostalpha and Ostbeta promoters, which was confirmed by the finding that the deletion of IR-1 sequences abolished the response to FXR and LXRalpha. Furthermore, mutations in IR-1 reduced the FXR- and LXRalpha-dependent transactivation of Ostalpha/beta. Together with the detection of direct binding of FXR/RXRalpha and LXRalpha/RXRalpha to the IR-1 elements, the presence of functional FXRE/LXRE was revealed in the promoter region of both Ostalpha and Ostbeta. In addition, the stimulatory effect of FXR/RXRalpha and LXRalpha/RXRalpha on Ostalpha, but not on Ostbeta, was further enhanced by HNF-4alpha.
CONCLUSIONS: It was concluded that LXRalpha/RXRalpha transcriptionally regulate mouse Ostalpha/beta via IR-1 elements shared with FXR/RXRalpha. Exposure to FXR/LXRalpha modulators may affect the disposition of Ostalpha/beta substrates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17177110     DOI: 10.1007/s11095-006-9163-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  36 in total

1.  Role of the breast cancer resistance protein (ABCG2) in drug transport.

Authors:  Qingcheng Mao; Jashvant D Unadkat
Journal:  AAPS J       Date:  2005-05-11       Impact factor: 4.009

2.  Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.

Authors:  George K Dresser; Richard B Kim; David G Bailey
Journal:  Clin Pharmacol Ther       Date:  2005-03       Impact factor: 6.875

3.  Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids.

Authors:  Tamara Frankenberg; Anuradha Rao; Frank Chen; Jamie Haywood; Benjamin L Shneider; Paul A Dawson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-12-15       Impact factor: 4.052

Review 4.  Nuclear receptors and drug disposition gene regulation.

Authors:  Rommel G Tirona; Richard B Kim
Journal:  J Pharm Sci       Date:  2005-06       Impact factor: 3.534

5.  The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.

Authors:  Jean-François Landrier; Jyrki J Eloranta; Stephan R Vavricka; Gerd A Kullak-Ublick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-11-03       Impact factor: 4.052

6.  Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine.

Authors:  Daniel Rost; Sven Mahner; Yuichi Sugiyama; Wolfgang Stremmel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-04       Impact factor: 4.052

7.  Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer.

Authors:  J Grober; I Zaghini; H Fujii; S A Jones; S A Kliewer; T M Willson; T Ono; P Besnard
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

8.  Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B.

Authors:  Hiroki Satoh; Fumiaki Yamashita; Masayuki Tsujimoto; Hideyasu Murakami; Noriko Koyabu; Hisakazu Ohtani; Yasufumi Sawada
Journal:  Drug Metab Dispos       Date:  2005-01-07       Impact factor: 3.922

9.  Cholesterol dependent downregulation of mouse and human apical sodium dependent bile acid transporter (ASBT) gene expression: molecular mechanism and physiological consequences.

Authors:  C Thomas; J-F Landrier; D Gaillard; J Grober; M-C Monnot; A Athias; P Besnard
Journal:  Gut       Date:  2006-02-16       Impact factor: 23.059

10.  Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene.

Authors:  Diana Jung; Bruno Hagenbuch; Michael Fried; Peter J Meier; Gerd A Kullak-Ublick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-12-30       Impact factor: 4.052

View more
  17 in total

1.  FXR silencing in human colon cancer by DNA methylation and KRAS signaling.

Authors:  Ann M Bailey; Le Zhan; Dipen Maru; Imad Shureiqi; Curtis R Pickering; Galina Kiriakova; Julie Izzo; Nan He; Caimiao Wei; Veerabhadran Baladandayuthapani; Han Liang; Scott Kopetz; Garth Powis; Grace L Guo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-31       Impact factor: 4.052

Review 2.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

3.  Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury.

Authors:  Melina M Malinen; Izna Ali; Jacqueline Bezençon; James J Beaudoin; Kim L R Brouwer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-02-08       Impact factor: 4.052

Review 4.  Bile acid transporters: structure, function, regulation and pathophysiological implications.

Authors:  Waddah A Alrefai; Ravinder K Gill
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

Review 5.  Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

Authors:  James J Beaudoin; Kim L R Brouwer; Melina M Malinen
Journal:  Pharmacol Ther       Date:  2020-04-02       Impact factor: 12.310

Review 6.  Bile acid transporters in health and disease.

Authors:  A Kosters; S J Karpen
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

Review 7.  Bile acid transporters.

Authors:  Paul A Dawson; Tian Lan; Anuradha Rao
Journal:  J Lipid Res       Date:  2009-06-04       Impact factor: 5.922

8.  FIC1-mediated stimulation of FXR activity is decreased with PFIC1 mutations in HepG2 cells.

Authors:  Saori Koh; Tappei Takada; Ikuya Kukuu; Hiroshi Suzuki
Journal:  J Gastroenterol       Date:  2009-04-21       Impact factor: 7.527

9.  Protein expression and function of organic anion transporters in short-term and long-term cultures of Huh7 human hepatoma cells.

Authors:  Melina M Malinen; Katsuaki Ito; Hee Eun Kang; Paavo Honkakoski; Kim L R Brouwer
Journal:  Eur J Pharm Sci       Date:  2019-01-24       Impact factor: 4.384

Review 10.  The heteromeric organic solute transporter, OSTα-OSTβ/SLC51: a transporter for steroid-derived molecules.

Authors:  Nazzareno Ballatori; Whitney V Christian; Sadie G Wheeler; Christine L Hammond
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.